Image

NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment

NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment

Recruiting
24-34 years
All
Phase N/A

Powered by AI

Overview

NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.

Eligibility

Inclusion Criteria for preterm infants:

  • born between 24 and 33 6/7 weeks GA;
  • ready for SSC

Inclusion criteria for mothers and fathers:

  • agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant;
  • mothers express breast milk for their preterm infants
        For twin births (twin pregnancies), fathers will also be invited to participate in the
        study, so that both infants can participate in the study.
        Exclusion criteria for preterm infants:
          -  congenital anomalies or genetic disorders
          -  intraventricular hemorrhage > grade II
          -  are small for GA defined as birth weight <10th percentile
          -  on postnatal day 19 (maximum days targeted for study start)
          -  are still receiving analgesics, sedatives, paralyzing agents
          -  are under mechanical ventilation
        Exclusion criteria mothers and fathers:
          -  are aged <18 years;
          -  have a physical condition that does not allow the SSC
          -  abuse illicit substances or alcohol that could influence stress, anxiety and parent-
             child interactions
          -  feed their preterm infant exclusively with commercial infant formula
          -  mothers had a breast surgery that could influence their breast milk production
          -  do not speak, read or write in French or in English

Study details
    Neurodevelopmental Disorders

NCT06087744

St. Justine's Hospital

29 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.